pharmaceutical-investing Zynerba Pharmaceuticals Reports First Quarter 2018 Financial Results and Operational Highlights
pharmaceutical-investing Clementia Initiates Phase 2 MO-Ped Trial for Palovarotene in Patients with Multiple Osteochondromas
Bio-Path Announces Interim Data from Phase 2 Clinical Trial of Prexigebersen in Combination with Low Dose Cytarabine
pharmaceutical-investing Insmed Submits New Drug Application to FDA for ALIS in NTM Lung Disease Caused by MAC
pharmaceutical-investing Menlo Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
pharmaceutical-investing Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update
pharmaceutical-investing Positive Phase 1/2 Results of AKCEA-APOCIII-LRx Presented at American College of Cardiology Annual Scientific Session & Expo
pharmaceutical-investing Bavarian Nordic Announces Additional Positive Data from a Phase 2 Study of its Universal RSV Vaccine
